Stay updated on Anamorelin HCl in NSCLC-C: Clinical Trial
Sign up to get notified when there's something new on the Anamorelin HCl in NSCLC-C: Clinical Trial page.

Latest updates to the Anamorelin HCl in NSCLC-C: Clinical Trial page
- Check6 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded a new Revision: v3.4.2 note and removed the previous government-operating-status notice along with the prior Revision: v3.4.1 entry.SummaryDifference0.3%

- Check41 days agoChange DetectedAdded a site-wide government funding notice indicating potential delays and that the NIH Clinical Center is open, and updated the revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check48 days agoChange DetectedThe page now includes minor UI/label updates and metadata changes: a Show glossary option, capitalization tweaks to QC-related labels, and a new revision tag (v3.4.0), with no changes to core study data, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision: v3.3.4 is now shown in the page header, replacing Revision: v3.3.3.SummaryDifference0.0%

- Check84 days agoChange DetectedAdded a consolidated Locations section listing participating sites across US states, Australia, and Canada. Updated the page revision to v3.3.3.SummaryDifference1%

Stay in the know with updates to Anamorelin HCl in NSCLC-C: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anamorelin HCl in NSCLC-C: Clinical Trial page.